Effects of VLDL and remnant particles on platelets. - Wikidata - awgldk - TriplyDB

Effects of VLDL and remnant particles on platelets.

Effects of VLDL and remnant particles on platelets.

http://www.wikidata.org/entity/Q36551304

about

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease Risk factors for venous and arterial thrombosis Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL).Platelet function in the postprandial period Variability of clopidogrel response in patients with type 2 diabetes mellitus.Platelet function profiles in patients with diabetes mellitus.Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans.Does Lipid Profile Affect Thrombin Generation During Ramadan Fasting in Patients With Cardiovascular Risks?Hypertriglyceridemia and atherosclerosis.Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects.Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

P2860

Q24608464-6F2A349A-B7BC-4EDE-97BF-B246EB352ECF Q26745946-B6DE87D4-609C-4548-AA62-061EE59D6B22 Q34988616-630FEAEC-1049-4CD8-B518-2826C34EE629 Q35744555-08A86B13-B7F9-4717-8C94-7892D18460E7 Q36411981-D98F5C6F-A26F-4FA1-A803-9EA5F1309AD5 Q37936014-83943AE5-6F62-4487-B101-29CA5EC1A933 Q38081078-21EEA8D4-245D-47D9-A1C8-EF63DE9697A8 Q40238161-F52037BE-269B-4A45-BFA5-01B10B5D1C5B Q46622541-F803B7BC-DA59-4045-B334-34A5E8FE1C2C Q47180199-276DF6D3-1D91-4B17-8951-5E89DF683147 Q55555524-41FA9739-1C7B-4FEA-A579-4891D1CDD889 Q57098021-9035B709-E709-40AF-9982-CF8A4F340E71 Q57274310-82505066-69D4-468C-A2D4-88905E05935F

P2860

Effects of VLDL and remnant particles on platelets.

http://www.wikidata.org/entity/Q36551304

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Effects of VLDL and remnant particles on platelets.

@ast

Effects of VLDL and remnant particles on platelets.

@en

type

label

Effects of VLDL and remnant particles on platelets.

@ast

Effects of VLDL and remnant particles on platelets.

@en

prefLabel

Effects of VLDL and remnant particles on platelets.

@ast

Effects of VLDL and remnant particles on platelets.

@en

P1433

Q36551304-8E73770B-51DA-4D88-AC24-CDC1F3FC22CE

P1476

Q36551304-18E2CA3B-83F9-4602-9FC9-10FEF208A2F2

P2093

Q36551304-103C7C22-4439-4243-9CEA-619B8D56D9BB

Q36551304-2CFCF929-BD8B-4BE2-9DE4-2D8EBB708D11

P2860

Q36551304-071E8DA9-4D6E-4727-B36E-48BAFC36605F

Q36551304-45D51719-FE12-4C20-B1FF-B67D821E5BEB

Q36551304-4B30AD62-A5BF-4A2C-9C06-82919870BB6A

Q36551304-59934D51-FDA9-4F60-8293-98CA631BBB4D

Q36551304-6DBD9902-2BA4-4BE8-A5B4-DA9BB161DFD1

Q36551304-B60693D5-ED50-4652-8EF9-8A7FBA3C0508

Q36551304-D4B4BEE6-D802-4789-88FF-B7001E10667F

P304

Q36551304-71D37D34-ACBB-417D-AB5D-B03ADCB44979

P31

Q36551304-CAC93AE8-F2B5-4DB3-B45F-020D5DF6C663

P356

Q36551304-FD69E69D-2098-4D67-9732-AE9442BD1864

P433

Q36551304-D6F166C9-607F-4192-8C6F-F309EDEC165D

P478

Q36551304-445FF635-E8B7-4273-9D48-FB60000656EE

P577

Q36551304-F3C93A96-7F1E-43FD-A0AE-0438128FAA04

P698

Q36551304-9A8A8BC5-06A7-4ED7-A53B-9FC9162F514F

P356

P1433

Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research

P1476

Effects of VLDL and remnant particles on platelets.

@en

P2093

Christopher D Byrne

http://www.w3.org/2001/XMLSchema#string

Rasaq Olufadi

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents

Plasminogen-activator inhibitor type 1 and coronary artery disease.

Evidence that triglycerides are an independent coronary heart disease risk factor.

Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency.

The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study.

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes.

P304

281-291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000093221

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16877877

http://www.w3.org/2001/XMLSchema#string